Concepedia

A double‐blind, randomized, placebo‐controlled dose‐ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome

Bardhan, Bodemar, Geldof, Schütz, Heath, Mills, Jacques Jacques

Alimentary Pharmacology & Therapeutics · 2000 · 162 citations · 15 references

DOIFull text

Open access

Abstract

Alosetron at a dose of 2 mg b.d. is an effective treatment for female patients with irritable bowel syndrome.

References

15

Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease

Nathan Mantel, William Haenszel · JNCI Journal of the National Cancer Institute · 1959 · 14.8K citations

, , +18

U. S. Householder survey of functional gastrointestinal disorders

Douglas A. Drossman, Zhiming Li, Eileen Andruzzi et al. · Digestive Diseases and Sciences · 1993 · 2.2K citations

, , +2

Epidemiology of colonic symptoms and the irritable bowel syndrome

N. J. Talley, A. R. Zinsmeister, Carol Van Dyke et al. · Gastroenterology · 1991 · 656 citations

, , +3

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT<sub>3</sub> receptor antagonist

Camilleri, Mayer, Drossman et al. · Alimentary Pharmacology & Therapeutics · 1999 · 372 citations · Full text

Irritable bowel syndrome in office-based practice in the United States

James E. Everhart, Pierre F. Renault · Gastroenterology · 1991 · 308 citations

, , +2